Publications by authors named "Ruth Swann"

Claim this Profile
C
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study.
Matthew E Barclay, Sean McPhail, Shane A Johnson, Ruth Swann, John Butler

Cancer Epidemiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.
Matthew E Barclay, Sean McPhail, Shane A Johnson, Ruth Swann, Christian J Finley

BMJ Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit.
Samuel Wd Merriel, Nurunnahar Akter, Nadine Zakkak, Ruth Swann, Sean McPhail

Br J Gen Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in the use of primary care-led investigations prior to a cancer diagnosis: analysis of the National Cancer Diagnosis Audit.
Nurunnahar Akter, Georgios Lyratzopoulos, Ruth Swann, Greg Rubin, Sean McPhail

BMJ Qual Saf· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and consequences of different pathways to emergency diagnosis of cancer in England: Evidence from linked national audit and cancer registration data.
Ruth Swann, Georgios Lyratzopoulos, Greg Rubin, Lucy Elliss-Brookes, Sean McPhail

Cancer Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International variation in chemotherapy use in cancer - Authors' reply.
Matthew E Barclay, Sean McPhail, Shane A Johnson, Ruth Swann, Georgios Lyratzopoulos

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Sean McPhail, Matthew E Barclay, Shane A Johnson, Ruth Swann, Riaz Alvi

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Sean McPhail, Matthew E Barclay, Ruth Swann, Shane A Johnson, Riaz Alvi

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis.
Ruth Swann, Sean McPhail, Gary A Abel, Jana Witt, Lorna Wills

Br J Gen Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Referral Primary Care Blood Tests and Symptom Presentation before Cancer Diagnosis: National Cancer Diagnosis Audit Data.
Ben M Cranfield, Gary A Abel, Ruth Swann, Sarah F Moore, Sean McPhail

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary care blood tests before cancer diagnosis: National Cancer Diagnosis Audit data.
Ben M Cranfield, Minjoung Monica Koo, Gary A Abel, Ruth Swann, Sean McPhail

Br J Gen Pract· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and measures of the diagnostic process in primary care for patients subsequently diagnosed with cancer.
Minjoung M Koo, Ruth Swann, Sean McPhail, Gary A Abel, Cristina Renzi

Fam Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
Sean McPhail, Ruth Swann, Shane A Johnson, Matthew E Barclay, Hazem Abd Elkader

Lancet Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care data.
Minjoung Monica Koo, Ruth Swann, Sean McPhail, Gary A Abel, Cristina Renzi

Cancer Epidemiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of geography on Scottish cancer diagnoses in primary care: Results from a national cancer diagnosis audit.
Peter Murchie, Rosalind Adam, Wei Lynn Khor, Sarah Smith, Emma McNair, Ruth Swann

Cancer Epidemiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer diagnosis in Scottish primary care: Results from the National Cancer Diagnosis Audit.
Peter Murchie, Rosalind Adam, Emma McNair, Ruth Swann, Jana Witt

Eur J Cancer Care (Engl)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The frequency, nature and impact of GP-assessed avoidable delays in a population-based cohort of cancer patients.
Ruth Swann, Georgios Lyratzopoulos, Greg Rubin, Elizabeth Pickworth, Sean McPhail

Cancer Epidemiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.
Minjoung Monica Koo, Ruth Swann, Sean McPhail, Gary A Abel, Lucy Elliss-Brookes

Lancet Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.
Ruth Swann, Sean McPhail, Jana Witt, Brian Shand, Gary A Abel

Br J Gen Pract· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion.
Simon A Fry, Claire E Robertson, Ruth Swann, Miriam V Dwek

Br J Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Ruth Swann

J Natl Cancer Inst· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Amanda B Spurdle, Fergus J Couch, Michael T Parsons, Lesley McGuffog, Daniel Barrowdale, Ruth Swann

Breast Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor stromal phenotypes define VEGF sensitivity--response.
Neil R Smith, Dawn Baker, Matthew Farren, Aurelien Pommier, Ruth Swann

Clin Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
Elinor Sawyer, Rebecca Roylance, Christos Petridis, Mark N Brook, Salpie Nowinski, Ruth Swann

PLoS Genet· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy.
Neil R Smith, Dawn Baker, Matthew Farren, Aurelien Pommier, Ruth Swann

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis